Sec. 505. Preventing overdoses of controlled substances
515 words·~2 min read·
/bill/115/s/2680/is/section-505A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Part J of title III of the Public Health Service Act ( 42 U.S.C. 280b et seq.), as amended by section 504, is further amended by inserting after section 392A the following: The Director of the Centers for Disease Control and Prevention (referred to in this section as the Director ), using the authority provided to the Director under section 392, may— to the extent practicable, carry out and expand any prevention activity described in paragraph (2); provide training and technical assistance to States, localities, and Indian tribes to carrying out any such activity; and award grants to States, localities, and tribes for the purpose of carrying out any such activity.
A prevention activity described in this paragraph is an activity to improve the efficiency and use of a new or currently operating prescription drug monitoring program— encouraging all authorized users (as specified by the State or other entity) to register with and use the program; enabling such users to access any data updates in as close to real-time as practicable; providing for a mechanism for the program to notify authorized users of any potential misuse or abuse of controlled substances and any detection of inappropriate prescribing practices relating to such substances; encouraging the analysis of prescription drug monitoring data for purposes of providing de-identified, aggregate reports based on such analysis to State public health agencies, State licensing boards, and other appropriate State agencies, as permitted under applicable Federal and State law and the policies of the prescription drug monitoring program and not containing any protected health information, to prevent inappropriate prescribing, drug diversion, or abuse and misuse of controlled substances, and to facilitate better coordination among agencies; enhancing interoperability between the program and any health information technology (including certified health information technology), including by integrating program data into such technology; updating program capabilities to respond to technological innovation for purposes of appropriately addressing the occurrence and evolution of controlled substance overdoses; and facilitating and encouraging data exchange between the program and the prescription drug monitoring programs of other States.
The Director may award grants to States, localities, and Indian tribes— to carry out innovative projects for grantees to rapidly respond to controlled substance misuse, abuse, and overdoses, including changes in patterns of controlled substance use; and for any other evidence-based activity for preventing controlled substance misuse, abuse, and overdoses as the Director determines appropriate. The Director may conduct studies and evaluations to address substance use disorders, including preventing substance use disorders or other related topics the Director determines appropriate.
Pursuant to section 102 of the Comprehensive Addiction and Recovery Act of 2016, the Director may advance the education and awareness of prescribers and the public regarding the risk of abuse of prescription opioids. In this section, the term controlled substance has the meaning given that term in section 102 of the Controlled Substances Act. For purposes of carrying out this section, section 392A of this Act, and section 102 of the Comprehensive Addiction and Recovery Act of 2016, there is authorized to be appropriated $486,000,000 for each of fiscal years 2019 through 2024. .
Connectionstraces to 1
Traces to 1 document
U.S. Code
Citation graph
cites case law
Sec. 505
Preventing overdoses of controlled substances
Cites 1Cited by 0 across 0 sources